MedPath

A Study of whether Jatamansi (Nordostachys jatamansi DC) fant along with conventional treatment is more effective in managing post COVID anxiety than conventional method alone.

Phase 2
Conditions
Health Condition 1: F418- Other specified anxiety disorders
Registration Number
CTRI/2023/02/050096
Lead Sponsor
Vd Mahesh Tambe
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Post covid patients of Mild and Moderate anxiety of age group 16-80 yrs. will be selected irrespective of their gender and religion.

2.As per clinical examination and specific anxiety disorder scale post covid patients fulfilling the criteria of Mild and Moderate anxiety will be selected.

3.Patients willing to give consent to participate in the trial.

Exclusion Criteria

1.Patients with known case of serious illness such as cancer, kidney disease, heart disease.

2.Patients with known case of Mental retardation or having any other psychological disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath